These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25853309)

  • 21. Stabilisation of amorphous ibuprofen in Upsalite, a mesoporous magnesium carbonate, as an approach to increasing the aqueous solubility of poorly soluble drugs.
    Zhang P; Forsgren J; Strømme M
    Int J Pharm; 2014 Sep; 472(1-2):185-91. PubMed ID: 24950364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery - An update.
    Jermain SV; Brough C; Williams RO
    Int J Pharm; 2018 Jan; 535(1-2):379-392. PubMed ID: 29128423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo.
    Tuomela A; Liu P; Puranen J; Rönkkö S; Laaksonen T; Kalesnykas G; Oksala O; Ilkka J; Laru J; Järvinen K; Hirvonen J; Peltonen L
    Int J Pharm; 2014 Jun; 467(1-2):34-41. PubMed ID: 24680962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system.
    Pouton CW
    Eur J Pharm Sci; 2006 Nov; 29(3-4):278-87. PubMed ID: 16815001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basics of Compounding-Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1.
    Allen LV
    Int J Pharm Compd; 2018; 22(3):220-228. PubMed ID: 29878890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral formulation strategies to improve solubility of poorly water-soluble drugs.
    Singh A; Worku ZA; Van den Mooter G
    Expert Opin Drug Deliv; 2011 Oct; 8(10):1361-78. PubMed ID: 21810062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced dissolution performance of curcumin with the use of supersaturatable formulations.
    Gosangari S; Dyakonov T
    Pharm Dev Technol; 2013; 18(2):475-80. PubMed ID: 22881446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
    Buckley ST; Frank KJ; Fricker G; Brandl M
    Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced oral bioavailability of a poorly water soluble drug PNU-91325 by supersaturatable formulations.
    Gao P; Guyton ME; Huang T; Bauer JM; Stefanski KJ; Lu Q
    Drug Dev Ind Pharm; 2004 Feb; 30(2):221-9. PubMed ID: 15089057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review: physical chemistry of solid dispersions.
    Janssens S; Van den Mooter G
    J Pharm Pharmacol; 2009 Dec; 61(12):1571-86. PubMed ID: 19958579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In silico prediction of the solubility advantage for amorphous drugs - Are there property-based rules for drug discovery and early pharmaceutical development?
    Kuentz M; Imanidis G
    Eur J Pharm Sci; 2013 Feb; 48(3):554-62. PubMed ID: 23262058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanocrystal-based per-oral itraconazole delivery: superior in vitro dissolution enhancement versus Sporanox® is not realized in in vivo drug absorption.
    Sarnes A; Kovalainen M; Häkkinen MR; Laaksonen T; Laru J; Kiesvaara J; Ilkka J; Oksala O; Rönkkö S; Järvinen K; Hirvonen J; Peltonen L
    J Control Release; 2014 Apr; 180():109-16. PubMed ID: 24566254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Functional Excipients in Solid Oral Dosage Forms to Overcome Poor Drug Dissolution and Bioavailability.
    van der Merwe J; Steenekamp J; Steyn D; Hamman J
    Pharmaceutics; 2020 Apr; 12(5):. PubMed ID: 32344802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs.
    Gursoy RN; Benita S
    Biomed Pharmacother; 2004 Apr; 58(3):173-82. PubMed ID: 15082340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solid self-nanoemulsifying delivery systems as a platform technology for formulation of poorly soluble drugs.
    Bansal T; Mustafa G; Khan ZI; Ahmad FJ; Khar RK; Talegaonkar S
    Crit Rev Ther Drug Carrier Syst; 2008; 25(1):63-116. PubMed ID: 18540836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on preparation of carbamazepine (CBZ) supersaturatable self-microemulsifying (S-SMEDDS) formulation and relative bioavailability in beagle dogs.
    Zhang N; Zhang W; Jin Y; Quan DQ
    Pharm Dev Technol; 2011 Aug; 16(4):415-21. PubMed ID: 20433250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Degrees of order: A comparison of nanocrystal and amorphous solids for poorly soluble drugs.
    Peltonen L; Strachan CJ
    Int J Pharm; 2020 Aug; 586():119492. PubMed ID: 32505579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug nanosuspensions: a ZIP tool between traditional and innovative pharmaceutical formulations.
    Leone F; Cavalli R
    Expert Opin Drug Deliv; 2015; 12(10):1607-25. PubMed ID: 25960000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.